Model
Edge
Alnylam Pharmaceuticals, Inc.
0001446125
Filing Type
144
Filing Date
6/1/2025
Updated
6/2/25, 2:08 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities